Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Grasemann reports grants from Vertex Pharmaceutical, during the conduct of the study.
Conflict of interest: Ms. Klingel has nothing to disclose.
Conflict of interest: Dr. Avolio has nothing to disclose.
Conflict of interest: Dr. Prentice has nothing to disclose.
Conflict of interest: Dr. Tullis reports grants and personal fees from Vertex Pharmaceuticals, during the conduct of the study; grants and personal fees from Proteostasis, outside the submitted work.
Conflict of interest: Dr. Ratjen reports grants and personal fees from Vertex, personal fees from Novartis, personal fees from Bayer, personal fees from Roche, personal fees from Genetech, outside the submitted work.
Conflict of interest: Tanja Gonska received funding from Vertex pharmaceutical incl for parts of the ivacaftor observational study.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received June 11, 2019.
- Accepted September 18, 2019.
- Copyright ©ERS 2019